The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs

Arch Dermatol Res. 1999 Feb-Mar;291(2-3):104-6. doi: 10.1007/s004030050391.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Dexamethasone / therapeutic use
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical / methods
  • Humans
  • Mice
  • Mice, SCID*
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Quinolines / therapeutic use
  • Skin Transplantation

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Quinolines
  • 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid
  • Dexamethasone